Yue Huang

15PUBLICATIONS
111CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)Cheminformatics and quantitative structure-activity relationshipsCharacterisation of biological macromoleculesGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-Refractory KRASG12C-Mutant NSCLC for Immune Checkpoint Blockade.

Xing Wei, Cristina Blaj, M Ali Al-Radhawi

|May 15, 2025
Investigations of Enteric-Coated Tablet Propyl Gallate-Induced Nephrotoxicity in Beagles as well as Human and Dog Renal Proximal Tubule Epithelial Cells.

Si Mou, B Timothy Hummer, Jiaqi Yuan

|Mar 11, 2025
Streamlined High-Throughput Data Analysis Workflow for Antibody-Drug Conjugate Biotransformation Characterization.

Kate Liu, Yongling Ai, Hui Yin Tan

|Feb 24, 2025
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers.

James Cregg, Kristof Pota, Aidan C A Tomlinson

|Jan 16, 2025
Detailed Structural Elucidation of Antibody-Drug Conjugate Biotransformation Species Using High Resolution Multiple Reaction Monitoring Mass Spectrometry with Orthogonal Dissociation Methods.

Junyan Yang, Hui Yin Tan, Jiaqi Yuan

|Oct 11, 2024
Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying Its Stability In Vivo.

Yue Huang, Hui Yin Tan, Jiaqi Yuan

Pageof 3

Frequent Collaborators

13 joint publications

Anton I Rosenbaum

6 joint publications

Jiaqi Yuan

4 joint publications

Hui Yin Tan

2 joint publications

Xing Wei